“…At the moment in vivo studies are mandatory for an accurate inclusion of GaHV‐2 strains into one of the known pathotypes. The meq gene polymorphism is also useful to create epidemiological molecular linkages between various GaHV‐2 strains, according to the numerous studies that have been recently published from various countries: China (Tian et al, ; Yu et al, ; Zhang, Liu, Zhang, Shi, & Li, ), Poland (Woźniakowski & Samorek‐Salamonowicz, ), USA (Padhi & Parcell, ), Colombia (Lòpez‐Osorio et al, ), Egypt (Abdallah et al, ; Hassanin, Abdallah, & El‐Araby, ), India (Gupta, Deka, & Ramneek, ; Prathibha, Sreedevi, Vinod Kumar, & Srilatha, ; Suresh, Johnson Rajeswar, Sukumar, Harikrishnan, & Srinivasan, ) and Japan (Abd‐Ellatieff et al, ).…”